World Kidney Day 2021: Living Well With Kidney Disease
The World Kidney Day Steering Committee has declared 2021 the year of “Living Well with Kidney Disease”.
Diagnosis & Disease Information
The Pandemic: Urgency Again Propels Medical Research Into the Real World
Strong motivation often provides the push to translate investigational technologies into real-world clinical use. Case in point: messenger RNA vaccines.
Time to Say Goodbye to the DRE for Prostate Cancer Screening
With the advent of more reliable and accurate ways to screen for prostate cancer, such as PSA testing and prostate MRI, the authors argue that it is time to stop the “antiquated practice” of the digital rectal examination.
Dialysis Is Not Going Away Anytime Soon
Dialysis is not likely to become obsolete despite advances — and nephrology goes way beyond renal replacement therapy.
Zoom Medicine: An Apt Metaphor in 2020
The practice of medicine is to the life sciences what finance and economics are to the mathematical disciplines. Both are wedged between STEM subjects and the humanities requiring skills emanating from both the right and left brain. Read any student’s application to medical school or residency program as they explain why medicine’s intersection of science…
Expanding Options for Kidney Failure Patients
Gradual transition to dialysis and palliative dialysis should be alternatives offered to patients with advanced chronic kidney disease, according to an editorial.
The COVID-19 Pandemic Proves the World Is Small
The rapid spread of coronavirus disease 2019 (COVID- 19) caught the world by surprise. Whatever becomes the new normal, the United States will be a different country from what it was on March 13, when President Donald J. Trump declared a national emergency. At this writing on May 28, more than 100,000 people in the…
Basic Science: The Tail That Wags the RCC Dog
I recently had reason to survey the progress made in renal cell cancer (RCC) over the last 70 or more years. In 1950, a patient who presented with metastatic RCC had a 0%-5% overall response rate (ORR) to the therapies of the time, with an anticipated overall survival (OS) of approximately 10 months. By 2005,…
That Nebulous Concept Called Standard of Care
During a session at the 2019 Genitourinary Cancers Symposium (GUCS) held recently in San Francisco, researchers presented findings from phase 3 studies showing that immunotherapy-based combination regimens are superior to sunitinib alone at improving progression-free survival among patients with previously untreated advanced kidney cancer. One study demonstrated improved overall survival. The study presenters concluded that…
Is ESCO the Future of Dialysis Care?
ESCOs are accountable for clinical quality outcomes and financial outcomes.
- Loading...
Loading...
Next post in Commentary
Loading... 
Loading...